medigraphic.com
SPANISH

Revista Mexicana de Neurociencia

Academia Mexicana de Neurología, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 3

<< Back Next >>

Rev Mex Neuroci 2016; 17 (3)

Neuropsychological characterization of ADHD with anxiety, and its association of single-nucleotide polymorphisms of the DGKH gene in a pediatric population

Polanco-Barreto ÁM, Arboleda-Bustos H, Pinto MC, Ávila JE, Vásquez R
Full text How to cite this article

Language: Spanish
References: 39
Page: 39-48
PDF size: 154.16 Kb.


Key words:

Anxiety disorder, attention deficit hyperactivity disorder, comorbidity, DGKH gene, neuropsychological characterization, polymorphisms.

ABSTRACT

Introduction: The attention deficit hyperactivity disorder (ADHD) is one of the most frequent psychiatric disorders in children. It has been identified that 60% of patients have comorbidity with other disorders such as learning disorders, anxiety, affective disorders, tics, obsessivecompulsive disorders, and other behavior. The presence of polymorphisms of the DGKH gene has been described in affective disorders, schizophrenia and ADHD, becoming a focus of attention in the analysis of the functioning of some prefrontal mechanisms.
Objective: To conduct a neuropsychological characterization of comorbid ADHD patients with anxiety disorder (AD) and to explore a possible association of two common polymorphisms (rs1170169 and rs9525580) of DGKH gene, in a sample of school children and adolescents from Colombia.
Material and methods: A total of 30 diagnosed cases with ADHD and AD were included, as well as 29 patients with ADHD without comorbidity and 33 controls. For the association of polymorphisms, the technique used was a standard PCR and the respective analyzes were performed through bioinformatics and statistical methods.
Results: Children diagnosed with comorbid ADHD with AD had a low cognitive performance globally. This difference is significant, compared to the group without comorbidity and the control group. The single nucleotide polymorphism (SNP) rs1170169 was found to be significantly protective for patients with comorbid ADHD with AD as well as for the AD group without the disorder (OR: 0.39, 95% CI: 0.198–0.6873; p=0.01097). On the other hand, we identified that the gene variant rs9525580 was associated with ADHD without comorbidity, as compared with controls (OR: 2.5, 95% CI: 1.191–5.248; p=0.01).
Conclusions: Common gene polymorphisms of the DGKH gene may be associated with both ADHD and ADHD with comorbidities phenotypes. This study adds to the understanding of geneenvironment relationship in children with ADHD.


REFERENCES

  1. Pineda D, Ardila A, Rosselli M, Arias BE, Henao GC, Gomez L, et al. Prevalence on the Attention Deficit Hiperactivity Simptoms in four – to -17 years General Population Children. J Abnorm Child Psychol 1999; 27: 455–462.

  2. Pineda D, Lopera F, Palacio JD, Ramirez D, Henao GC. Prevalence Estimation of Attention – Deficit/ Hyperactivity Disorder: Differencial Diagnoses and Comorbilidades in a Columbian Sample. Int J Neurosci 2003; 113: 49 -72.

  3. López I, Rodillo E, Kleinsteubers K, Neurobiología y Diagnóstico del Trastorno por Déficit de Atención. Rev Médica 2008; 19: 511-524.

  4. Dueñas O. Bases Biológicas del Trastorno por Déficit de la Atención e Hiperactividad. Revista Internacional de Psicología 2005; 6: 1-35.

  5. Bierdeman J, Newcorn J, Sprich S. Comorbidity of Attention Deficit Disorden Wich Conduct Depressive, Anxiety and other Disorders. American Journal of Psyquiatry 1991; 148: 564-577.

  6. Benedet MJ. Neuropsicología Cognitiva. Aplicaciones a la Clínica y a la Investigación Fundamento Teórico y Medológico de la Neuropsicología Cognitiva Edición: 2002.

  7. Faraone SV, Biederman J, Weber W, et al. Psychiatric, Neuropsychological, and Psychosocial Features of DSM IV Subtypes of Attention Deficit Hyperactivity Disorder, Results from a Clinically Referred Sample J Am Acad Child Adolesc Psychiatry 1998; 37: 185-192.

  8. Comings DE, Gade-Andavolu R, Gonzalez N, et al. Multivariate Analysis of Associations of 42 Genes in ADHD, ODD and Conduct Disorder. Clin Genet 2000; 58: 31-40.

  9. Ronald A, Pennell C, Whitehouse A, Prenatal Maternal Stress Associated With ADHD and Autistic Traits in Early Chidhood. Front Psychol 2010; 1: 223.

  10. Steergiakouli E, Thapar A, Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD). Neuropsychiatr Dis Treat 2010; 6: 551–560.

  11. Lesch KP, Timmesfeld N, Renner TJ, et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 2008; 115: 1573-1585.

  12. Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 2009; 32: 267-287.

  13. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, Georgi A, Schumacher J. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13: 197-207.

  14. http://www.genecards.org/cgi-bin/carddisp.pl?gene=DGKH

  15. Moya PR, Murphy DL, McMahon FJ, Wendland JR. Increased gene expression of diacylglycerol kinase η in bipolar disorder. Int J Neuropsychopharmacol 2010; 13: 1127-1128.

  16. Chen G, Henter I, Manji H. A Role for PKC in Mediating Stress- Induced Prefrontal Cortical Structural Plasticity and Cognitive Function Proc Natl Acad Sci U S A 2009; 106: 17613-17614.

  17. Hains A, Arnsten A. Molecular Mechanisms of Stress- Induced Prefrontal Cortical Impairment: Implications for Mental Illness. Learn mem 2008 15: 551-564.

  18. Rossi L, Neer R, Lopetegui S. Test de matrices progresivas de RAVEN: Construcción de Baremos y Constatación de Efecto Flynn. Orientación y sociedad – 2001/2002; 3: 2-11.

  19. Programa EstadisticoMinitap 15.http://www.minitab.com/es-ES/

  20. Purcell S, Neale B, Todd K-Brown, Thomas L, et al. American Journal of Human Genetics, Plink 2007. www.mgh.harvard.edu/purcell/plink/.

  21. http://hapmap.ncbi.nlm.nih.gov/cgi-perl/gbrowse/hapmap28_B36/#search

  22. Weber H, Kittel S, Gessner A, Domschke K, Neuner M, Jacob C, Buttenschon M, Boreatti A. Cross – Disorder Analysis of Bipolar Risk Genes: Furtheerr Evidence of DGKH as a Risk Gene for Bipolar Disorder, but also Unipolar Depression and Adult ADHD. Neuropsycopharmacology 2011; 36: 2076-2085.

  23. www.primer3.wi.mit.edu

  24. www.idtdna.com/analyzer/applications/oligoanalyzer.

  25. Willcut EG, Pennington BF, Boada R, Ogline JS, Tunick RA, Chhabildas NA. A comparision of the cognitive deficits in reading disability and attention – deficit/hiperactivity disorder. J Abnorm Psychol 2001; 110: 157-172.

  26. Martínez M, Henao GC, Gómez LA. Comorbilidad del trastorno por déficit de atención e hiperactividad con los trastornos específicos del aprendizaje. Rev Colomb Psiquiat 2009; 38: 178- 194.

  27. Toren P, Sadeh M, Wolmer L, Eldar S, et al. Neurocognitive correlates of anxiety disorders in children: a preliminary report. Journal of anxiety disorders 2000; 14: 239-247.

  28. Airaksinen E, Larsson M, ForselloY. Neuropsychological functions in anxiety disorders in population based samples: evidence of episodic memory dysfunction. Journal of Psychatric Research 2005; 39: 207-214.

  29. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. The Neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioral inhibition as candidate endophenotypic markers. Neuroscience and biobehavorial reviews 2005; 29: 399-419.

  30. García E, Vigotski. La construcción histórica de la Psique. México 2010.

  31. Rivas M. Procesos cognitivos y aprendizaje significativo. Consejería de Educación comunidad Madrid, 2008.

  32. Bayes M, Ramos-Quiroga JA, Cormand B, et al. Large – Scale Gentyping in Research into Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder. Rev Neurol 2005; 40: 187-190.

  33. Xu XJ, Zhou K, et al. Family – Based Association Study Between Brain- Derived Neurotrophic Factor gene polymorphisms and Attention Deficit Hyperactivity Disorder in Uk and Taiwanese Samples. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 83-86.

  34. Dorval KMJ, Wigg KG, Grosbie J, et al. Association of the Glutamate Receptor Subunit Gene GRIN2B with Attention-Deficit/Hiperactivity Disorder. Genes Brain Behav 2007; 6: 444-452.

  35. Lewis CM. Genetic Association Studies: design, analysis and interpretation. Brief Bioinform 2002; 3: 146-153.

  36. Llorca J, Prieto D, Combarros O, Dierssen T, Berciano J. Riesgos competitivos de muerte y equilibrio de Hardy- Weinberg en estudios de casos y controles sobre asociación entre genes y enfermedades. GacSanit 2005; 19: 321-324.

  37. http://www.ncbi.nlm.nih.gov/gene/160851

  38. Anderson CA, Pettersson FH, et al. Data Quality Control in Genetic case-control Association Studies. Nat Protoc 2010; 5: 1564-1573.

  39. Biederman J, Milberger S, Faraone S, Kiely K, Guite J, Mick E, et al. Family-environment risk factors for ADHD: A test of Rutter’s indicators of adversity. Arch Gen Psychiatry 1995; 52: 464-470.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Neuroci. 2016;17